Abstract
Oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases such as Parkinson's disease (PD). Neuronal death in the substantia nigra of PD patients is partly caused by exacerbated oxidative damage. Our previous studies demonstrated that oxidative stress can alter the structure and stability of neuro-filament (NF) proteins and that 17-α- and 17-β-estradiol are potent neuroprotective agents. The aim of this study was to investigate the cytoskeletal target of neuroprotection by estrogens in neuronal PC12 cells. We induced oxidative stress by MPP+ administration for 24 h, and 17-α- and 17-β-estradiol were used as neuroprotective drugs. We measured gene expression and protein expression of each NF subunit, NFL, NFM, and NFH, by semiquantitative RT-PCR, Western blot, and immunofluorescence. Our results demonstrate that NFL mRNA and protein levels are not modulated by MPP+ or estradiol isomers, whereas NFM gene expression, as well as protein expression, are strongly influenced by MPP+, 17-α-, and 17-β-estradiol after a 24-h treatment. Finally, mRNA levels of the most phosphorylated subunits, NFH, are not changed by MPP+ or treatment with both estradiol isomers, whereas NFH protein expression is decreased by the same treatments. These results suggest that oxidative stress affects neuronal cytoskeleton, maybe though proteolysis and/or abnormal structural changes in NFs. Then, 17-α- and 17-β-estradiol might help the neuronal cell in recovering after oxidative stress by inducing protein expression of NFM and NFH subunits.
Similar content being viewed by others
References
Al-Chalabi A. and Miller C. C. (2003) Neurofilaments and neurological disease. Bioessays 25(4), 346–355.
Amantea D., Russo R., Bagetta G., and Corasaniti M. T. (2005) From clinicalevidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52(2), 119–132.
Anneser J. (2002) Molecular basis of treatment in motor neurone disease. Neurol. Sci. 21(Suppl. 5), S913-S918.
Bains J. S. and Shaw C. A. (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 25(3), 335–358.
Barp J., Araujo A. S., Fernandes T. R., Rigatto K. V., Llesuy S., Bello-Klein A. and Singal P. (2002) Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz. J. Med. Biol. Res 35(9), 1075–1081.
Berlett B. S. and Stadtman E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272(33) 20,313–20,316.
Bjorkdahl C., Sjogren M. J., Winblad B. and Pei J. J. (2005) Zinc induces neurofilament phosphorylation independent of p70S6 kinase in N2a cells. Neuroreport 16(6), 591–595.
Bomont P., Cavalier L., Blondeau F., Ben Hamida C., Belal S., Tazir M., et al. (2000), The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet 26(3), 370–374.
Booth, E. A., Marchesi M., Kilbourne E. J. and Lucchesi B. R. (2003) 17β-estradiol as a receptor-mediated cardioprotective agent. J. Pharmacol. Exp. Ther. 307(1), 395–401.
Callier S., Morissette M., Grandbois M. and Di Paolo T. (2000) Stereospecific prevention by 17β-estradiol of MPTP-induced dopamine depletion in mice. Synapse 37(4), 245–251.
Carter J., Gragerov A., Konvicka K., Elder G., Weinstein H., and Lazzarini R. A. (1998) Neurofilament (NF) assembly: divergent characteristics of human and rodent NF-L subunits. J. Biol. Chem. 273(9), 5101–5108.
Dave K. R., Bradley W. G. and Perez-Pinzon M. A. (2003) Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse. Exp. Neurol. 182(2), 412–420.
De Girolamo L. A., Hargreaves A. J. and Billett E. E. (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells. J. Neurochem. 76(3), 650–660.
Dluzen D. E. (2000) Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J. Neurocytol. 29(5–6), 387–399.
Egana J. T., Zambrano C., Nunez M. T., Gonzalez-Billault C., and Maccioni R. B. (2003). Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures. Biometals 16(1), 215–223.
Fall C. P. and Bennett J. P. Jr. (1999) Characterization and time course of MPP+-induced apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 55(5), 620–628.
Farah C. A., Nguyen M. D., Julien J. P. and Leclerc N. (2003) Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 84(1), 77–86.
Gagne B., Gelinas S., Bureau G., Lagace B., Ramassamy C., Chiasson K., et al. (2003). Effects of estradiol, phyto-estrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress. Endocrine 21(1), 89–95.
Garcia-Segura L. M., Azcoitia I., and DonCarlos L. L. (2001) Neuroprotection by estradiol. Prog. Neurobiol. 63(1), 29–60.
Gelinas S. and Martinoli M. G. (2002) Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J. Neurosci. Res. 70(1), 90–96.
Gelinas S., Bureau G., Valastro B., Massicotte G., Cicchetti F., Chiasson K., et al. (2004) Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress. Neurotox. Res. 6(2), 141–148.
Gelinas S., Chapados C., Beauregard M., Gosselin I., and Martinoli M. G. (2000) Effect of oxidative stress on stability and structure of neurofilament proteins. Biochem. Cell Biol. 78(6), 667–674.
Gomez-Mancilla B. and Bedard P. J. (1992) Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys. Neurosci. Lett. 135(1), 129–132.
Gong C. X., Wang J. Z., Iqbal K. and Grundke-Iqbal I. (2003) Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci. Lett. 340(2), 107–110.
Green P. S. and Simpkins J. W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18(4–5), 347–358.
Hale S. L., Birnbaum Y. and Kloner R. A. (1997) Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits. J. Cardiovasc. Pharmacol. Ther. 2(1), 47–52.
Han H. J., Park S. H., Park H. J., Park K. M., Kang J. W., Lee J. H., et al. (2002) Effect of various oestrogens on cell injury and alteration of apical transporters induced by tert-butyl hydroperoxide in renal proximal tubule cells. Clin. Exp. Pharmacol. Physiol. 29(1–2), 60–67.
Hand C. K. and Rouleau G. A. (2002) Familiar amyotrophic lateral sclerosis. Muscle Nerve 25(2) 135–139.
Hirano A. (1994) Hirano bodies and related neuronal inclusions. Neuropathol. Appl. Neurobiol. 20(1), 3–11.
Itano Y., Kitamura Y. and Nomura Y. (1994) 1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: inhibitory effects of several drugs. Neurochem. Int. 25(5) 419–424.
Jayaraman D., Giasson B. I. and Mushynski W. E. (1995) Increased phosphorylation of neurofila ment subunits in PC12 cells and rat dorsal root ganglion neurons treated with N-Acetyl-Leu-Leu-norleucinal. Int J. Dev. Neurosci. 13(7), 753–758.
Jenner P. (2003), Oxidative stress in Parkinson's disease. Ann. Neurol. 53(Suppl. 3), S26-S36.
Kajta M. and Beyer C. (2003) Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 21(1), 3–9.
Kam K. W., Qi J. S., Chen M. and Wong, T. M. (2004) Estrogen reduces cardiac injury and expression of beta 1-adrenoceptor upon ischemic insult in the rat heart. J. Pharmacol. Exp. Ther. 309(1), 8–15.
Kocaturk P. A., Akbostanci M. C., Tan F. and Kavas G. O. (2000) Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease. Pathophysiology 7(1), 63–67.
Kosta, P., Argyropoulou M. I., Markoula S. and Konitsiotis S. (2005) MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J. Neurol 253, 26–32.
Lee V., Trojanowski J. Q., and Schlaepfer W. W. (1982) Induction of neurofilament trip let proteins in PC12 cells by nerve growth factor. Brain Res. 238(1), 169–180.
Leranth C., Roth R. H., Elsworth J. D., Naftolin F., Horvath T. L., and Redmond D. E. Jr. (2000) Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J. Neurosci. 20(23), 8604–8609.
Leranth C., Shanabrough M., and Redmond D. E. Jr. (2002) Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates. J. Comp. Neurol. 447(1), 34–42.
Leterrier J. F. and Eyer J. (1992) Age-dependent changes in the ultrastructure and in the molecular composition of rat brain microtubules. J. Neurochem. 59(3), 1126–1137.
Lindenbaum M. H., Carbonetto S., and Mushynski W. E. (1987) Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells. J. Biol. Chem. 262(2), 605–610.
Liu Q., Raina A. K., Smith M. A., Sayre L. M., and Perry G. (2003) hydroxynonenal, tocxic carbonyl, and Alzheimer disease. Mol. Aspects Med. 24, 305–313.
Liu S. J., Fang Z. Y., Yang Y., Deng H. M., and Wang J. Z. (2003) Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo. Acta Pharmacol. Sin. 24(6), 512–518.
Ma Z. Q., Spreafico E., Pollio G., Santagati S., Conti, E., Cattaneo E., and Maggi A. (1993) Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc. Natl. Acad. Sci. U. S. A. 90(8), 3740–3744.
MacLusky N. J., Chalmers-Redman R., Kay G., Ju W., Nethrapalli I. S., and Tatton W. G. (2003) Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons. Neuroscience 118(3), 741–754.
Miller D. B., Ali S. F., O'Callaghan J. P., and Laws S. C. (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N. Y. Acad. Sci. 844, 153–165.
Mitsumoto H., and Gambetti P. (1986) Impaired slow axonal transport in wobbler mouse motor neuron disease. Ann. Neurol. 19(1), 36–43.
Mori H., Oda M., and Mizuno Y. (1996) Cortical ballooned neurons in progressive supranuclear palsy. Neurosci. Lett. 209(2), 109–112.
Nilsen J., Mor G., and Naftolin F. (1998) Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 5(4), 211–216.
Perez-Olle R., Lopez-Toledano M. A., Goryunov D., Cabrera-Poch N., Stefanis L., Brown K., and Liem R. K. (2005) Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J. Neurochem. 93(4), 861–874.
Pernas-Alonso R., Perrone-Capano C., Volpicelli F., and di Porzio U. (2001) Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes in Wobbler neurom uscular disease. Neuro biol. Dis. 8(4), 581–589.
Pernas-Alonso R., Schaffner A. E., Perrone-Capano C., Orlando A., Morelli F., Hansen C. T., et al. (1996), Early upregulation of medium neurofilament gene expression in developing spinal cord of the Wobbler mouse mutant. Brain Res. Mol. Brain Res. 38(2), 267–275.
Pong K. (2003) Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin. Biol. Ther. 3(1), 127–139.
Radunovic A., Porto W. G., Zeman S., and Leigh P. N. (1997) Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex. Neurosci. Lett. 239(2–3), 105–108.
Rahaman S. O., Ghosh S., Mohanakumar K. P., Das S., and Sakar P. K. (2001) Hypothyroidism in the developing rat brain is associated with marked oxidative stress and aberrant intraneuronal accumulation of neurofilaments. Neurosci. Res. 40, 273–279.
Ramirez A. D., Liu X., and Menniti F. S. (2003) Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice. Neuroendocrinology 77(4), 223–231.
Rau S. W., Dubal D. B., Bottner M., Gerhold L. M., and Wise P. M. (2003) Estradiolattenuates programmed cell death after stroke-like injury. J. Neurosci. 23(36), 11420–11426.
Rousseau J., Cossette L., Grenier S., and Martinoli M.-G. (2002) Modulation of prolactin expression by xeno-estrogens. Gen. Comp. Endocrinol. 126, 175–182.
Ruiz-Larrea M. B., Garrido M. J., and Lacort M. (1993). Estradiol-induced effects on glutathione metabolism in rat hepatocytes. J. Biochem. (Tokyo) 113(5), 563–567.
Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54(3), 823–827.
Schapira A. H., Holt I. J., Sweeney M., Harding A. E., Jenner P., and Marsden C. D. (1990b) Mitochondrial DNA analysis in Parkinson's disease. Mov. Disord. 5(4), 294–297.
Schimmelpfeng J., Weibezahn K. F., and Dertinger H. (2004) Quantification of NGF-dependent neuronal differentiation of PC-12 cells by means of neurofilament-LmRNA expression and neuronal outgrowth. J. Neurosci. Methods 139(2), 299–306.
Schmidt R. E., Beaudet L. N., Plurad S. B., and Dorsey D. A. (1997) A xonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia. Brain Res. 769(2), 375–383.
Schmittgen T. D., and Zakrajsek B. A. (2000) Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J. Biochem. Biophys. Methods 46(1–2), 69–81.
Schober A. (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318(1), 215–224.
Schon E. A. and Manfredi G. (2003) Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. 111(3), 303–312.
Scoville S. A., Bufton S. M., and Liuzzi F. J. (1997) Estrogen regulates neurofilament gene expression in adult female rat dorsal root ganglion neurons. Exp. Neurol. 146(2), 596–599.
Shepherd C. E., McCann H., Thiel E., and Halliday G. M. (2002) Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies. Neurobiol Dis. 9(2), 249–257.
Smeyne R. J., and Jackson-Lewis V. (2005) The MPTP model of Parkinson's disease. Brain Res. Mol. Brain Res. 134(1), 57–66.
Smith D. S., and Tsai L. H. (2002) Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol. 12(1), 28–36.
Stadtman E. R., and Berlett B. S. (1997) Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10(5), 485–494.
Topalli I., and Etgen A. M. (2004) Insulin-like growth factor-I receptor and estrogen receptor crosstalk mediates horm one-induced neurite outgrowth in PC12 cells. Brain Res. 1030(1), 116–124.
Toran-A'llerand C. D. (2004) Estrogen and the brain: beyond ER-alpha and ER-beta. Exp. Gerontol. 39(11–12), 1579–1586.
Toung T. J., Traystman R. J., and Hurn P. D. (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29(8), 1666–1670.
Trimpin S., Mixon A. E., Stapels M. D., Kim M. Y., Spencer P. S., and Deinzer M. L. (2004) Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry. Biochemistry 43(7), 2091–2105.
Wise, P. M., Dubal D. B., Wilson M. E., Rau S. W., and Liu Y. (2001) Estrogens: trophic and protective factors in the adult brain. Front. Neuroendocrinol. 22(1), 33–66.
Wise P. M. (2002) Estrogens and neuroprotection. Trends Endocrinol. Metab. 13, 229–230.
Yang S. H., Liu R., Wu S. S., and Simpkins J. W. (2003) The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann. N. Y. Acad. Sci. 1007, 101–107.
Zecca L., Berg D., Arzberger T., Ruprecht P., Rausch W. D., Musicco M., et al. (2005) In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage. Mov. Disord. 20, 1278–1285.
Zhang H., Joseph J., Feix J., Hogg N., and Kalyanaraman B. (2001) Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry 40(25), 7675–7686.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Chiasson, K., Lahaie-Collins, V., Bournival, J. et al. Oxidative stress and 17-α- and 17-β-estradiol modulate neurofilaments differently. J Mol Neurosci 30, 297–310 (2006). https://doi.org/10.1385/JMN:30:3:297
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:30:3:297